With the development of radioimmunoassay (RIA),1 measurements of the serum concentrations of peptide hormones have become routine. A few peptide hormones have remained extraordinarily difficult to measure even with this technique.
Parathyroid hormone (PTH) is among these.
The principal difficulty in the RIA assay of PTH lies in the production of a high-affinity, high-titer antibody.
Aubert (1) has speculated that this phenomenon is inherent in the relatively small size and lack of tertiary structure-and hence rigidity-of peptide molecules such as ACTH and PTH. But beyond this there still remain some difficulties with the R!A of PTH. A basic assumption in RIA is that standard curves parallel dilution curves of the material under assay. In our experience, which includes work with several antisera that cross-react with human serum and serum samples from more than 100 individuals, this condition is met only rarely in PTH assays. PTH is nonspecifically bound very readily, not only to glass but apparently also to other serum proteins. Nevertheless, it is obviously possible (2-5) to obtain clinically useful measurements of PTH in serum by RIA. From To circumvent the lack of parallelism, as well as a high degree of binding of PTH by serum, we have developed an assay system in which more control tubes and a greater number of sample dilutions are used than is customary.
A benefit that accrues from this approach is that data can be obtained with antisera of relatively low titer, which are of limited usefulness in conventional RIA systems.
Materials and Methods

lodination
The labeling procedure that we used for PTH is the classic Hunter-Greenwood iodination procedure (6) . Amounts of radiolabel and hormone used are 4 mCi of radioactive iodine to 5 sg of pure bovine PTH (4). We have used two bovine PTH preparations, one a gift from C. Arnaud (Mayo Clinic, Rochester, Minn.), the other material purchased from C. Hawker (University of Pennsylvania, Philadelphia, Pa.), each of which exhibited a single protein band by disc gel electrophoresis.
Either 1311 or 1251 have been used for iodination, with very similar results as far as incorporation of the label and lack of damage to the hormone are concerned. Because of its longer half-life we prefer to use 125! because the frozen compound appears to be stable over the useful half-life of the radioactive label. The specific activity of the iodinated hormone in our preparations is about 400 sCi/g of hormone.
Incubation
Optimum concentrations of antibody (Ab) and tag (radioactive compound) in the incubation mixtures are determined from avidity curves. That for Ab is determined initially, for each new batch of Ab and then needs to be repeated only at long intervals, perhaps yearly, for the same lot of antibody.
That for tag is obtained for every new iodination but involves only a few tubes. Our current work has dealt principally with three antibpdies: a chicken antibody to porcine PTH (Ch-14); a guinea pig antibody to bovine PTH (W-Ab), purchased from Wilson Laboratories, Chicago, Ill.; and a guinea pig antibody to bovine PTH (BW-Ab), commercially available from Burroughs Wellcome Co., London, England. A characteristic series of avidity curves, those for the Ch-14 antiserum, are shown in Figure 1 . It follows that a Incubation systems were studied extensively. The protocol we eventually adopted follows:
Diluent: barbital buffer (0.1 mol/liter, pH 8.6) containing, per liter, 100 ml of human parathyroidfree serum2 and 50 ml of Trasylol (FBA Pharmaceuticals, N.Y.; 500,000 kallikrein inactivator units per 50 ml). Relatively high final protein concentrations are necessary to prevent adsorption of the PTH onto the available glass surfaces.
Serum to be assayed, appropriately diluted with diluent if necessary.
Antibody diluted with diluent to yield final concentrations in the incubation mixture ranging from 1:1000 for W-Ab; 1:3000 for Ch-14 Ab to 1:300,000 for the BW antibody.
The iodinated PTH (the "tag") is also diluted with diluent. The count per preparation varies with the iodination and the age of the tag. It should be based on the avidity curve, which is run for each new iodination with the antibody to be used in the analysis.
With use of the BW-Ab, 24 tubes are set up for each unknown according to the protocol shown in 2Although we prefer to use serum from parathyroidectomized human subjects, we have on occasion substituted normal human serum treated with QUSO (Corning CPG 10-240 Column Packing). Tubes and reagents are kept on ice throughout the pipetting procedure.
The racks containing diluent, antibody, and unknown are incubated on a shaker in the cold room at 4#{176}C for about 48 h. Tag is then added and the tubes are re-incubated at 4#{176}C on the shaker for another 16-20 h.
All antisera tested-including a rabbit antiserum to bovine PTH3 that was only weakly cross-reactive with human serum-gave excellent standard curves with purified bovine PTH in the concentration range 10 ng to 100 ng. Standardization of human PTH assays with bovine hormone leads to difficulties _#{149}__#{149}.
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as S. The upper curve represents results for serum. diluent, tag, and antibody; the middle (control) curve those for serum. diluent, and tag (but no antibody); and the solid line represents the calculated differential between the two. The earlier protocols, exemplified here, were based on eight dilution points for each run, in duplicate. In more recent protocols ( Table  1) pension of dextran-coated charcoal (7). Tubes and charcoal suspension are kept on ice throughout the separation procedure and each set of tubes is centrifuged at 6000 rpm for 20 mm at 4#{176}C shortly after the charcoal is added, Both charcoal and supernatant fluid are counted for about 10,000 counts on a gamma counter (Nuclear Chicago, 1185 Series).
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Results and Discussion
The characteristic pattern obtained with an unknown serum is shown in Figure 2 . The upper, dashed curve represents the tubes containing antiserum in addition to tag, sample, and diluent; the middle, dotted curve represents the tubes containing diluent in lieu of antiserum; and the bottom, solid curve is the calculated differential between these two. The extent of nonspecific binding of the radiolabel (presumably to serum proteins) shown by the dotted curve makes it necessary to correct for this phenomenon.
The extent to which this occurs and its characteristics-i.e., the shape of the dotted curveis reproducible for a given serum but varies from sample to sample. Theoretically, the differential curve should eventually approach a 0% bound value; in practice a rise is frequently encountered before this value is reached. Empirically, we have chosen to extrapolate our curves to the 0% bound value for calculation purposes. Since the initial inflection point (k) varies from curve to curve we have chosen the mid-point of the kim portion of the differential curve (see Figures 2 and 3) as the equivalence point. Comparison is then made against a standard curve obtained in the identical manner to the unknowns for a range of 10-200 pg of h-PTH. A standard curve (Figure 3) is included with each series of 9-10 unknowns, which comprise a run. Here too the calculated differential curve (curve C) is used for final calculations.
Essentially similar curves are obtained with the W-Ab (Figure 4 ) and the Ch-14 Ab. As Figure 4 indicates, the useful sample concentrations for the W-Ab are lower than for the BW-Ab; hence protocols were adjusted to bridge from 0.1 to 20
Several inflection points are frequently encountered with this Ab, therefore the use of a large number of serum concentrations per protocol becomes most important. This is illustrated further by considering the ambiguities which may occur if only two or three different concentrations are run for a given serum sample, as in serum (JW-i) has been used in this instance to obtain a standard curve. A percent trace (%T) calculation has been substituted for the percent bound (%B) used previously, which has the advantage of a positive correlation between %T and PTH concentration.
The "trace" is obtained by calculating bound to free (B/F) ratios for assay tubes containing only tag, Ab, and diluent. This ratio indicates the maximum B/F obtainable in the system. B/F ratios for standard and sample tubes are multiplied by 100 and divided by the "trace" to express results as %T.
With use of Ch-14 Ab, JW-i as a standard, the appropriate extrapolation, and 85%T as a reference point it follows that 4 h postoperatively the serum PTH concentrations of patient JW-2 had dropped from 1 zl equivalents/ml to 0.14 il equivalents. This compares to a normal concentration (N-JO) of 0.37 zl equivalents of PTH per ml of serum (see Figure 5 ). The weakness of the system lies in the lack of parallelism of the four curves, even over their apparently useful range. Figure 6 illustrates the additional problem frequently encountered with an Ab of low titer. Qualitatively similar results are obtained with the W-Ab as with the Ch-14 Ab, if one has prior knowledge of the JW-i serum. Without this knowledge a three-point curve leads to ambiguity, because it becomes difficult to decide whether the appropriate portion of the curve is the one between 1 and 2 tl of serum or that obtained after 3 zl.
Data obtained with the 12-point protocol, outlined in Table 1 , and the BW-Ab have been summarized in Table 2 .
In summary, the iodination procedure is simple and straightforward, and the incubation system has been designed to meet the major problems encountered in these analyses: the lack of parallelism among the various curves was circumvented by the method of calculation and the tendency of PTH to bind to incubation components other than the Ab is corrected by obtaining a curve for the nonspecific binding of each serum. The lack of parallelism has been ascribed by Habener et al. (8) to the presence in peripheral blood of various PTH fragments, all of which are immunologically competent. Another problem consistently encountered is that the portions of the curve in front of and following the RIAimportant ki segment (Figure 4 ) rarely have a slope 
